View in EDS HTML Full Text PDF Full Text

Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.

Saved in:
Bibliographic Details
Title: Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.
Authors: Kishk, Ali1 (AUTHOR), Pacheco, Maria Pires1 (AUTHOR), Heurtaux, Tony1,2 (AUTHOR), Sauter, Thomas1 (AUTHOR) Thomas.Sauter@uni.lu
Source: Briefings in Bioinformatics. May2024, Vol. 25 Issue 3, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14675463
DOI:10.1093/bib/bbae199